Discover how patient-derived organoid technology is transforming infectious disease research and drug development. Join us to explore: The science behind HUB Organoid Technology and its creation from ...

Pharma companies are collaborating to boost the power of artificial intelligence (AI) in drug discovery by allowing access to proprietary structural data to train a large language model. Each of the ...

An artificial-intelligence-driven drug discovery platform will receive a step up onto the Nasdaq via a reverse merger with a blank check company. Nanyang Biologics has been snapped up by Nasdaq-listed ...

Oct 1 (Reuters) - Bristol Myers Squibb (BMY.N), opens new tab, Takeda Pharmaceuticals (4502.T), opens new tab and Astex Pharmaceuticals are coming together to share proprietary data for training an ...

Scientists at Université de Montreal and its Institute for Research in Immunology and Cancer have begun a phase-1 clinical trial for a small-molecule therapy for solid tumors. The molecule inhibits ...

Artificial intelligence and machine learning are being embedded in every aspect of the drug discovery and development process. In the preclinical stages, for example, companies are using advanced AI ...

Local law enforcement is cracking down on drug crimes, making it clear those behind it will be dealt with accordingly. In a joint press conference on Oct. 1, representatives of the Leon County Sheriff ...

President Donald Trump speaks in the Oval Office of the White House, Tuesday, Sept. 30, 2025, in Washington. (Alex Brandon/AP) President Donald Trump has declared drug cartels to be unlawful ...

President Donald Trump is declaring drug cartels to be “unlawful combatants” and informed members of Congress the United States is in an “non-international armed conflict” with them. .“The president ...

University of Oregon researchers have tested a new combination drug therapy that could dismantle the difficult-to-treat bacteria inhabiting chronic wound infections. Their findings, publishedSept. 29 ...